Pfizer
(NYSE:PFE)
$27.7102
-0.2298[-0.82%]
At close: Mar 18
$27.7102
0[0.00%]
After Hours: 7:58PM EDT

GET A REPORT ON PFE SENT RIGHT TO YOUR INBOX

Pfizer Stock (NYSE:PFE), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Neutral
Highest Price Target1
$60.00
Lowest Price Target1
$27.00
Consensus Price Target1
$42.16

Analyst Rating Summary1

Analyst Ratings
Oct 23
4
7
Nov 23
1
2
Dec 23
2
2
Jan
2
1
Feb
1
Mar
2
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
Guggenheim
TD Cowen
Truist Securities
UBS

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Pfizer

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/04/2024PFEBuy Now
Pfizer
$27.7162.4%Cantor Fitzgerald
Louise Chen
→ $45ReiteratesOverweight → OverweightGet Alert
03/01/2024PFEBuy Now
Pfizer
$27.7162.4%Cantor Fitzgerald
Louise Chen
→ $45ReiteratesOverweight → OverweightGet Alert
02/23/2024PFEBuy Now
Pfizer
$27.7129.92%Guggenheim
Vamil Divan
→ $36Initiates → BuyGet Alert
01/31/2024PFEBuy Now
Pfizer
$27.7162.4%Cantor Fitzgerald
Louise Chen
→ $45ReiteratesOverweight → OverweightGet Alert
01/09/2024PFEBuy Now
Pfizer
$27.7162.4%Cantor Fitzgerald
Louise Chen
→ $45ReiteratesOverweight → OverweightGet Alert
01/04/2024PFEBuy Now
Pfizer
$27.7115.48%TD Cowen
Steve Scala
→ $32DowngradeOutperform → Market PerformGet Alert
12/14/2023PFEBuy Now
Pfizer
$27.7129.92%Truist Securities
Robyn Karnauskas
$42 → $36MaintainsBuyGet Alert
12/14/2023PFEBuy Now
Pfizer
$27.71-2.56%UBS
Colin Bristow
$34 → $27MaintainsNeutralGet Alert
12/14/2023PFEBuy Now
Pfizer
$27.711.05%Barclays
Carter Gould
$34 → $28MaintainsEqual-WeightGet Alert
12/04/2023PFEBuy Now
Pfizer
$27.7151.57%Truist Securities
Robyn Karnauskas
→ $42ReiteratesBuy → BuyGet Alert
11/20/2023PFEBuy Now
Pfizer
$27.71170.66%Cantor Fitzgerald
Louise Chen
→ $75ReiteratesOverweight → OverweightGet Alert
11/01/2023PFEBuy Now
Pfizer
$27.7122.7%Barclays
Carter Gould
$35 → $34MaintainsEqual-WeightGet Alert
11/01/2023PFEBuy Now
Pfizer
$27.7133.52%Morgan Stanley
Terence Flynn
$39 → $37MaintainsEqual-WeightGet Alert
10/20/2023PFEBuy Now
Pfizer
$27.7122.7%UBS
Colin Bristow
$36 → $34AssumesNeutral → NeutralGet Alert
10/17/2023PFEBuy Now
Pfizer
$27.7151.57%Truist Securities
Robyn Karnauskas
$62 → $42MaintainsBuyGet Alert
10/17/2023PFEBuy Now
Pfizer
$27.7140.74%Morgan Stanley
Terence Flynn
$40 → $39MaintainsEqual-WeightGet Alert
10/17/2023PFEBuy Now
Pfizer
$27.7126.31%Wells Fargo
Mohit Bansal
$39 → $35MaintainsEqual-WeightGet Alert
10/16/2023PFEBuy Now
Pfizer
$27.7119.09%BMO Capital
Evan David Seigerman
$44 → $33MaintainsOutperformGet Alert
10/16/2023PFEBuy Now
Pfizer
$27.7126.31%Citigroup
Andrew Baum
$42 → $35MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Pfizer (PFE)?

A

The latest price target for Pfizer (NYSE: PFE) was reported by Cantor Fitzgerald on March 4, 2024. The analyst firm set a price target for $45.00 expecting PFE to rise to within 12 months (a possible 62.40% upside). 46 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Pfizer (PFE)?

A

The latest analyst rating for Pfizer (NYSE: PFE) was provided by Cantor Fitzgerald, and Pfizer reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Pfizer (PFE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.

Q

Is the Analyst Rating Pfizer (PFE) correct?

A

While ratings are subjective and will change, the latest Pfizer (PFE) rating was a reiterated with a price target of $0.00 to $45.00. The current price Pfizer (PFE) is trading at is $27.71, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch